symptoms, persistent weakness, or exhaustion that limits daily activities, and also keep good habits that maintain muscle mass, keep hydrated, and blood sugar stable
This ensures that you do not have too much semaglutide in your system, which can cause side effects
The 15mg dose in the SURMOUNT-1 trial produced 20.2 percent average body weight loss at 72 weeks
13 February 2025 By Sarah Lowden & PA Media Initial research has indicated that low-dose semaglutide injections can reduce alcohol craving and some drinking outcomes, prompting calls for a larger clinical trial to evaluate GLP-1RAs for alcohol use disorder
About the SELECT trial SELECT was a randomised, double-blind, parallel-group, placebo-controlled trial designed to evaluate the efficacy of Wegovy (semaglutide 2.4 mg) versus placebo as an adjunct to standard of care for the prevention of MACE in people with overweight or obesity and established CVD with no prior history of diabetes
However, in the US, UK, and many parts of Europe, the patent protection for semaglutide lasts till 2031 and beyond